Fusion EML4:ALK, a known cancer driver prevalent in lung adenocarcinoma,30,31 has evidence of multiple transcript variant structures, and while microhomologies are found between the EML4 and ALK genes they tend to be distal from the fusion variant breakpoints (Figure 3A). Here, EML4 is linked to lung adenocarcinoma.